Eye tracking communication devices in amyotrophic lateral sclerosis: Impact on disability and quality of life

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 7-8, 2013, Pages 546-552

  Caligari, Marco ^a   Godi, Marco ^a   Guglielmetti, Simone ^a   Franchignoni, Franco ^a   Nardone, Antonio ^a,b  

^a IRCCS   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

ALS; Assistive technology; Augmentative and alternative communication; Eye tracking

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANARTHRIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; EYE TRACKING; EYE TRACKING COMMUNICATION DEVICE; FEMALE; HUMAN; INDIVIDUALLY PRIORITIZED PROBLEM ASSESSMENT SCALE; INTERPERSONAL COMMUNICATION; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOSOCIAL IMPACT OF ASSISTIVE DEVICES SCALE; QUADRIPLEGIA; QUALITY OF LIFE; QUEBEC USER EVALUATION OF SATISFACTION WITH ASSISTIVE TECHNOLOGY; RATING SCALE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; COMMUNICATION DISORDERS; CROSS-SECTIONAL STUDIES; DYSARTHRIA; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SELF-HELP DEVICES;

EID: 84887448272     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.803576     Document Type: Article

References (33)

1. LP, Schneider NA. A myotrophic lateral sclerosis. N Engl J Med. 2001; 344:1688-700.
2. Ball LJ, Beukelman DR, Pattee GL. C ommunication effectiveness of individuals with amyotrophic lateral sclerosis. J Commun Disord. 2004; 37:197-215.
3. Roth CR, Gleze LE, Goding GS Jr, David WS. S pasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis. J Voice. 1996; 10:362-7.
4. Tomik B, Guiloff RJ. D ysarthria in amyotrophic lateral sclerosis: a review. Amyotroph Lateral Scler. 2008; 00:1-12.
5. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009; 73:1218-26.
6. Beukelman D, Fager S, Nordness A. C ommunication Support for People with ALS. Neurol Res Int. 2011; 2011:714693.
7. Fager S, Beukelman DR, Fried-Oken M, Jakobs T, Baker J. Access interface strategies. Assist Technol. 2011; 24:25-33.
8. Caligari M. E nvironmental control and alternative augmentative communication in severe motor disability. G Ital Med Lav Ergon. 2009; 31:79-91.
9. Ball LJ, Nordness A S, Fager SK, Kersch K, Mohr B, Pattee GL, Beukelman DR. Eye gaze access to AAC technology for people with amyotrophic lateral sclerosis. J Med Speech Lang Pathol. 2010; 18:11-23.
10. Ball LJ, Fager S, Fried-Oken M. A ugmentative and a lternative communication for people with progressive neuromuscular disease. Phys Med Rehabil Clin N Am. 2012; 23:689-99.
11. De Filippi L. P untatori oculari: per essere ancora 'c onnessi ' col mondo (dissertation). Milano (Italy): Universit à Cattolica del Sacro Cuore; 2009.
12. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169:13-21.
13. Kasarskis E J, Dempsey-Hall L, Thompson M M, Luu L C, Mendiondo M, Kryscio R. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler. 2005; 6:50-4.
14. Kaufmann P, Levy G, Montes J, Buchsbaum R, Barsdorf AI, Battista V, et al. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicentre clinical trial. QALS study group. Amyotroph Lateral Scler. 2007; 8:42-6.
15. Wessels RD, de Witte L, Andrich R, Ferrario M, Perrson, J, Oberg, et al. IPPA, auser-centred approach to assess effectiveness of assistive technology provision. Technol Disabil. 2000; 13:105-15.
16. Light J. I nteraction involving individuals using augmentative and alternative communication systems: state of the art and future directions. Augment Altern Commun. 1988; 4:66-7.
17. Wessels R, Persson J, Lorentsen O, Andrich R, Ferrario M, Oortwijn, et al. IPPA: individually prioritized problem assessment. Technol Disabil. 2002; 14:141-5.
18. Jutai J, Day H. P sychosocial Impact of Assistive Devices Scale (PIADS). Technol Disabil. 2002; 14:107-11.
19. Day H, Campbell K. I s telephone assessment a valid tool in rehabilitation research and practice Disabil Rehabil. 2003; 25:1126-31.
20. Demers L, Weiss-Lambrou R, Ska B. The Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0): an overview and recent progress. Technol Disabil. 2002; 14:101-5.
21. Huggins JE, Wren P A, Gruis KL. W hat would brain-computer interface users want Opinions and priorities of potential users with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011; 12:318-24.
22. Ball LJ, Beukelman DR, Pattee GL. A cceptance of Augmentative and Alternative Communication Technology by Persons with Amyotrophic Lateral Sclerosis. Augment Altern Commun. 2004; 20:113-22.
23. Fried-Oken M, Fox 23. L, Rau MT, Tullman J, Baker G, Hindal M, et al. Purposes of AAC device use for persons with ALS as reported by caregivers. Augment Altern Commun. 2006; 22:209-21.
24. Murphy J. C ommunication strategies with of people with ALS and their partners. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5:212-26.
25. Mathy P, Yorkson K, Gutmann M. A ugmentative Communication for Individuals with Amyotrophic Lateral Sclerosis. In:Beukelman D, Yorkston K, Reichle J, editors. Augmentative and Alternative Communication in Adults with Acquired Neurologic Disorders. Baltimore: Paul H Brookes; 2000. p. 183-232.
26. Beukelman DR, Fager S, Ball L, Dietz A. A AC for adults with acquired neurological conditions: a review. Augment Altern Commun. 2007; 23:230-42.
27. Brownlee A, Palovcak M. The role of augmentative communication devices in the medical management of ALS. NeuroRehabilitation. 2007; 22:445-50.
28. Trioschi D, Bitelli C, Hoogerwerf EJ, Tanzini D. A AC and amyotrophic lateral sclerosis: a literature review and aspects of quality of life and service delivery. In:Emiliani PL, Burzagli L, Como A, Gabbanini F, Salminen AL, editors. Assistive Technology from Adapted Equipment to Inclusive Environments. AAATE 2009. Amsterdam: IOS Press; 2009. p. 3-7.
29. Doyle M, Phillips B. T rends in augmentative and alternative communication use by individuals with amyotrophic lateral sclerosis. Augment Altern Comm. 2001; 17:167-78.
30. Robarge K. C ommunication management in amyotrophic lateral sclerosis: the role of the speech-language pathologist during disease progression. Internet J Allied Health Sci Pract. 2009; 7:[about 6 p.]. Avaiable from: http://ijahsp.nova. edu/articles/Vol7Num2/robarge.htm 31. McNaughton D, Light J, Groszyk L. ' D on't give up':employment experiences of individuals with amyotrophic lateral sclerosis who use augmentative and alternative communication. Augment Altern Commun. 2001; 17:179-95.
31. Nordness A S, Ball LJ, Fager S, Beukelman D R, Pattee GL. Late AAC assessment for individuals with amyotrophic lateral sclerosis. J Med Speech Lang Pathol. 2010; 18:48-54.
32. Yorkston K M, Spencer K A, Duffy J R. B ehavioural management of respiratory/phonatory dysfunction from dysarthria: a systematic review of the evidence. J Med Speech Lang Pathol. 2003; 11:13-38.
33. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioural impairment (an evidence based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009; 73:1227-33.